antibodies to htlv-i in sera from patients with connective tissue diseases [letter]

NLM AIDSLINE Antibodies to HTLV-I in sera from patients with connective tissue diseases [letter] Irvine W; White P; Cambridge G
June 30, 1989

Ann Rheum Dis. 1989 Jan;48(1):80. Unique Identifier : AIDSLINE Connective Tissue Diseases/IMMUNOLOGY Human HTLV-I Antibodies/ANALYSIS HTLV-I Infections/*IMMUNOLOGY LETTER JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 GLOBAL: HIV Outcomes Could Improve by Integrating Treatment of Comorbid Mental Illness CANADA: Stop Paid Blood Donor Clinics in Toronto, Victims Say UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations HHS Office for Civil Rights launches campaign to increase awareness of HIPAA rights among HIV-positive Black men Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM Too many patients, too little time OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events CANADA: Fast, Cheap Methods of Diagnosing Infectious Disease? They're Coming Sooner Than You Think Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013 Legal help for AIDS patients NIH Scientists Create New Tool for Identifying Powerful HIV Antibodies: Advance Could Speed HIV Vaccine Research
Information in this article was accurate in June 30, 1989. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.